Research Topics
Genomes and GenesSpecies | J CorrealeSummaryCountry: Argentina Publications
| Collaborators
|
Detail Information
Publications
Oligoclonal bands and antibody responses in multiple sclerosisJorge Correale
Departmento de Neurologia, Instituto de Investigaciones Neurológicas, Dr Raúl Carrea, Buenos Aires, Argentina
J Neurol 249:375-89. 2002..The elucidation of the mechanisms and target(s) responsible for the onset of MS has obvious implications for the further development of specific therapies...
The risk of relapses in multiple sclerosis during systemic infectionsJorge Correale
Department of Neurology, Raul Carrea Institute for Neurological Research FLENI, Buenos Aires, Argentina
Neurology 67:652-9. 2006..To assess the risk of multiple sclerosis (MS) relapses, MRI activity, and T cell responses during systemic infections (SI) in patients with MS...
Association between parasite infection and immune responses in multiple sclerosisJorge Correale
Department of Neurology, Raul Carrea Institute for Neurological Research FLENI, Buenos Aires, Argentina
Ann Neurol 61:97-108. 2007..To assess whether parasite infection is correlated with a reduced number of exacerbations and altered immune reactivity in multiple sclerosis (MS)...
Benign multiple sclerosis: a new definition of this entity is neededJorge Correale
Department of Neurology, Institute for Neurological Research Raúl Carrea, FLENI, Buenos Aires, Argentina
Mult Scler 18:210-8. 2012..To study a cohort of benign multiple sclerosis (BMS) patients beyond physical disability, including the evaluation of cognitive and social function, as well as fatigue, pain and MRI studies...
The impact of environmental infections (parasites) on MS activityJorge Correale
Department of Neurology, Institute for Neurological Research Dr Raúl Carrea, FLENI, Argentina
Mult Scler 17:1162-9. 2011..Better understanding of host-parasite interactions caused by specific parasite molecules with immunomodulatory effects will help combat allergies and autoimmune disease without the price of untoward infection as a side-effect...
The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targetingJorge Correale
Department of Neurology, Institute for Neurological Research Dr Raúl Carrea, Montañeses 2325 1428, Buenos Aires, Argentina
Autoimmunity 40:148-60. 2007....
Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosisJorge Correale
Department of Neurology, Raul Carrea Institute for Neurological Research, FLENI, Buenos Aires, Argentina
Mult Scler 17:521-31. 2011..Recent studies conducted in arthritis, asthma, and inflammatory bowel disease suggest that chitinases are important in inflammatory processes and tissue remodeling...
Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjectsJorge Correale
Department of Neurology, Raul Carrea Institute for Neurological Research, Buenos Aires, Argentina
J Immunol 185:4948-58. 2010..Collectively, these results demonstrate estrogen-promoted differences in vitamin D(3) metabolism, suggesting a greater protective effect of vitamin D(3)-based therapeutic strategies in women...
Monocyte-derived dendritic cells in multiple sclerosis: the effect of bacterial infectionJorge Correale
Department of Neurology, Raul Carrea Institute for Neurological Research FLENI, Montaneses 2325, Buenos Aires, Argentina
J Neuroimmunol 190:177-89. 2007....
Isolation and characterization of CD8+ regulatory T cells in multiple sclerosisJorge Correale
Department of Neurology, Raul Carrea Institute for Neurological Research, FLENI, Montaneses 2325, 1428 Buenos Aires, Argentina
J Neuroimmunol 195:121-34. 2008..Moreover, IL-15 and IFN-gamma significantly increased CD94 and NKG2A expression. These data provide evidence that CD94/NKG2A receptors play an important role in regulating T cell activity during the course of MS...
Vaccines for multiple sclerosis: progress to dateJorge Correale
Department of Neurology, Raul Carrea Institute for Neurological Research, Buenos Aires, Argentina
CNS Drugs 22:175-98. 2008..Overall, vaccines for MS represent promising approaches for the treatment of this devastating disease, as well as other autoimmune diseases...
Helminth infections associated with multiple sclerosis induce regulatory B cellsJorge Correale
Department of Neurology, Raul Carrea Institute for Neurological Research FLENI, Buenos Aires, Argentina
Ann Neurol 64:187-99. 2008..To assess the importance of B-cell control during parasite infections in multiple sclerosis (MS) patients...
Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosisJorge Correale
Department of Neurology, Institute for Neurological Research Dr Raúl Carrea, FLENI, Buenos Aires, Argentina
Ann Neurol 67:625-38. 2010..The objective of this study was to investigate the role of CD8+ CD25+ FoxP3+ cells during the course of multiple sclerosis (MS)...
Cellular elements of the blood-brain barrierJorge Correale
Department of Neurology, Institute for Neurological Research Dr Raúl Carrea FLENI, Montaneses 2325, 1428 Buenos Aires, Argentina
Neurochem Res 34:2067-77. 2009..Tight junctions (TJs) present between ECs form an important barrier against diffusion, excluding most blood-borne substances for entering the brain...
Immunomodulatory effects of Vitamin D in multiple sclerosisJorge Correale
Raul Carrea Institute for Neurological Research, FLENI, Montaneses 2325, 1428 Buenos Aires, Argentina
Brain 132:1146-60. 2009..Collectively, these data suggest that 1,25(OH)(2)D(3) plays an important role in T cell homeostasis during the course of multiple sclerosis, thus making correction of its deficiency may be useful during treatment of the disease...
BHT-3009, a myelin basic protein-encoding plasmid for the treatment of multiple sclerosisJorge Correale
Raul Carrea Institute for Neurological Research FLENI, Department of Neurology, Buenos Aires, Argentina
Curr Opin Mol Ther 11:463-70. 2009..BHT-3009 appears to be a promising new approach for the treatment of MS, although further clinical trials are warranted to confirm the early findings...
[Neuronal injury in multiple sclerosis]Jorge Correale
Departamento de Neurologia, Instituto de Investigaciones Neurologicas Dr Raul Carrea FLENI, Facultad de Ciencias Biomédicas Universidad Austral, Buenos Aires, Argentina
Medicina (B Aires) 66:472-85. 2006..Recognition that MS is in part a neurodegenerative disease should trigger critical rethinking on the pathogenic mechanisms of this disease and provides new targets for a rational treatment...
Myelin basic protein and myelin oligodendrocyte glycoprotein T-cell repertoire in childhood and juvenile multiple sclerosisJorge Correale
Department of Neurology, Raul Carrea Institute for Neurological Research, FLENI, Montañeses 2325 1428, Buenos Aires, Argentina
Mult Scler 12:412-20. 2006....
T cell vaccination in secondary progressive multiple sclerosisJ Correale
Department of Neurology, USC School of Medicine, 1333 San Pablo Street, MCK 142, Los Angeles, CA 90033, USA
J Neuroimmunol 107:130-9. 2000..The data obtained indicated that TCV using autologous irradiated bovine myelin-reactive T cells promotes an effective depletion of T cells reactive against different myelin antigens...
Resistance to glucocorticoid-induced apoptosis in PLP peptide-specific T cell clones from patients with progressive MSJ Correale
Department of Neurology, University of Southern California, School of Medicine, 1333 San Pablo Street, MCK 142, Los Angeles, CA 90033, USA
J Neuroimmunol 109:197-210. 2000..Thus, failure to respond to GC treatment may reflect defect in apoptosis that develop during the progressive stages of chronic inflammatory disease...
[Immunological mechanisms involved in the pathogenesis of multiple sclerosis]J Correale
Departamento de Neurologia, Instituto de Investigaciones Neurologicas Dr Raul Carrea FLENI, Buenos Aires, Argentina
Rev Neurol 31:471-6. 2000..To summarize current knowledge of the immunological mechanisms involved in the pathogenesis of multiple sclerosis and its implications in the development of new therapeutic options...
[Current concepts on the use of some immunomodulatory drugs in the treatment of multiple sclerosis]J Correale
Departamento de Neurologia, Instituto de Investigaciones Neurológicas Dr Raúl Carrea, FLENI, Montaneses 2325, 1428 Buenos Aires, Argentina
Medicina (B Aires) 61:470-80. 2001..Several ongoing and planned clinical trials in various stages of disease will help to define further the role of these agents in the treatment of multiple sclerosis...
Time course of T-cell responses to MOG and MBP in patients with clinically isolated syndromesJorge Correale
Department of Neurology, Raul Carrea Institute for Neurological Research FLENI, Montaneses 2325, Buenos Aires 1428, Argentina
J Neuroimmunol 136:162-71. 2003..These data raise important issues for the pathogenesis and treatment of multiple sclerosis (MS)...
Temporal variations of adhesion molecules and matrix metalloproteinases in the course of MSJorge Correale
Department of Neurology, Raul Carrea Institute for Neurological Research FLENI, Montañeses 2325 1428, Buenos Aires, Argentina
J Neuroimmunol 140:198-209. 2003..These data suggest that VLA-4, LFA-1alpha and MMP-9 play a leading role in the evolution of inflammatory demyelinating lesions in patients with CIS who develop CDMS...
Vitamin D-mediated immune regulation in multiple sclerosisJorge Correale
Department of Neurology, Institute for Neurological Research Dr Raúl Carrea, FLENI, Buenos Aires, Argentina
J Neurol Sci 311:23-31. 2011..Collectively, these findings suggest that 1,25(OH)(2) VitaminD plays an important role in T cell homeostasis during the course of MS, suggesting correction of its deficiency may be useful during treatment of the disease...
The neuroprotective role of inflammation in nervous system injuriesJorge Correale
Raul Carrea Institute for Neurological Research, FLENI, Montaneses 2325, 1428, Buenos Aires, Argentina
J Neurol 251:1304-16. 2004..Therefore, the design of more effective therapies depends on a clear delineation of the beneficial and detrimental effects of inflammation...
Activation of humoral immunity and eosinophils in neuromyelitis opticaJorge Correale
Raul Carrea Institute for Neurological Research, FLENI, Montañeses 2325 1428, Buenos Aires, Argentina
Neurology 63:2363-70. 2004..To study immunologic alterations in patients with neuromyelitis optica (NMO)...
Mitoxantrone as rescue therapy in worsening relapsing-remitting MS patients receiving IFN-betaJorge Correale
Department of Neurology Raúl Carrea Institute for Neurological Research, FLENI, Montaneses 2325, 1428 Buenos Aires, Argentina
J Neuroimmunol 162:173-83. 2005..We conclude that brief courses of MX may provide a safe treatment alternative for RR MS patients who experience rapid and severe worsening of their disease despite IFN-beta treatment...
The impact of parasite infections on the course of multiple sclerosisJorge Correale
Department of Neurology, Institute for Neurological Research Dr Raúl Carrea, FLENI, Montaneses 2325, 1428 Buenos Aires, Argentina
J Neuroimmunol 233:6-11. 2011..These new observations on parasite infections associated to MS indicate that parasite regulation of host immunity can alter the course of MS...
Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanismsJorge Correale
Dr Raul Carrea Institute for Neurological Research, Foundation for the Fight against Childhood Neurological Diseases FLENI, Department of Neurology, Buenos Aires, Argentina
J Immunol 183:5999-6012. 2009..This knowledge could prove critical in developing novel therapeutic approaches for the treatment of autoimmune diseases such as MS...
Antigen presentation by autoreactive proteolipid protein peptide-specific T cell clones from chronic progressive multiple sclerosis patients: roles of co-stimulatory B7 molecules and IL-12J Correale
Department of Neurology, USC School of Medicine, Los Angeles 90033, USA
J Neuroimmunol 72:27-43. 1997..Together, these observations suggest that Ag presentation by T cells might amplify and perpetuate an autoimmune response previously initiated by professional APCs. These properties may account for progression of MS into a CP phase...
Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosisMaría C Ysrraelit
Department of Neurology, Raul Carrea Institute for Neurological Research, FLENI, Buenos Aires, Argentina
Neurology 71:1948-54. 2008..To investigate hypothalamic-pituitary-adrenal axis activity in well-defined multiple sclerosis (MS) patient subgroups...
Preliminary studies of cytokine secretion patterns associated with pregnancy in MS patientsWendy Gilmore
Department of Neurology, University of Southern California School of Medicine, Los Angeles 90033, USA
J Neurol Sci 224:69-76. 2004....
Prevalence of multiple sclerosis in Buenos Aires, Argentina using the capture-recapture methodE Cristiano
MS Section, Hospital Italiano, Buenos Aires, Argentina
Eur J Neurol 16:183-7. 2009..The objective of the study is to determine the prevalence of MS in a high populated area from Argentina (Greater Buenos Aires Metropolitan area) using the capture-recapture methodology...
[Recommendations for optimising the treatment of multiple sclerosis in Latin America]E Cristiano
Hospital Italiano, Buenos Aires, Argentina
Rev Neurol 44:494-8. 2007..In recent years the development of new drugs that have been shown to modify the natural history of MS have had a substantial impact on the treatment of the disease...
Focal stiff-person syndromeM Fiol
Department of Neurology, , Buenos Aires, Argentina
Neurologia 16:89-91. 2001..Definition of the range of clinical expression and immunological profiles could be important for the clinical management of these patients...
Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosisMauricio F Farez
Department of Neurology, Institute for Neurological Research Dr Raúl Carrea, Fundacion para la Lucha contra las Enfermedades Neurologicas de la Infancia, Buenos Aires, Argentina
Arch Neurol 68:1267-71. 2011..To investigate the effect of yellow fever (YF) immunization on the subsequent multiple sclerosis (MS) relapse risk...
Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell deathMarta A Toscano
División de Immunogenética Hospital de Clínicas José de San Martín, Facultad de Medicina, Universidad de Buenos Aires, C1120AAF Buenos Aires, Argentina
Nat Immunol 8:825-34. 2007..Our findings identify a molecular link among differential glycosylation of T helper cells, susceptibility to cell death and termination of the inflammatory response...
[Multiple sclerosis. Old observations, new hypotheses, future perspectives]Jorge Correale
Medicina (B Aires) 65:175-80. 2005

